Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05157399 · ClinicalTrials.gov registry record · NA
Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness
A NA study, sponsored by Otolith Labs.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT05157399 is a NA study that has completed, run by Otolith Labs. The registered enrollment target is 28 participants.
The verdict
NCT05157399, a NA study, has completed, sponsored by Otolith Labs.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
Vestibular disorders are among the most common causes of disability in society and affect over 50% of the population over the age of 65 and a significant percentage of the younger population. Vestibular disorders have a dramatic impact on daily life impacting work, relationships, and even activities of daily living.The OtoBand has shown promise and might be beneficial for treating or improving the course of recovery from vestibular disorders. This study seeks to quantify the effect of the study device, the OtoBand, on objective measures of dizziness and vertigo in patients with vestibular dysfunction. The study will be conducted at a single-site and will be a blinded, randomized, placebo-controlled design in which participants do not know if they are receiving bone conducted stimulation 1) at a therapeutic level or 2) at a non therapeutic level.
Interventions
- DEVICE Placebo Device
- DEVICE Otoband
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2021-11-04 |
| Est. Completion | 2022-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05157399
The ClinicalTrials.gov registry entry for NCT05157399 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Otolith Labs, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo Device is the first listed.
NCT05157399 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05157399 about?
NCT05157399 is a clinical study titled "Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness". Vestibular disorders are among the most common causes of disability in society and affect over 50% of the population over the age of 65 and a significant percentage of the younger population. Vestibular disorders have a dramatic impact on daily life impacting work, relationships, and even activities...
What is the current status of trial NCT05157399?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2021-11-04. Estimated completion is 2022-09-01.
What interventions are being tested in trial NCT05157399?
The interventions under investigation include: Placebo Device (DEVICE), Otoband (DEVICE).
Who is sponsoring clinical trial NCT05157399?
This trial is sponsored by Otolith Labs, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.